Dr. Navid Mahabadi, DO

Dr. Mahabadi practices at High Desert Medical Group in Lancaster, California.

Dr. Mahabadi's NPI, 1679193221, was assigned on April 23, 2020. Dr. Mahabadi graduated from Arizona School of Dentistry and Oral Health - Mesa in 2019. Dr. Mahabadi holds California license 20A21906.

Dr. Mahabadi's primary practice is High Desert Medical Group, at 43839 15th W St, Lancaster, CA 93534. The practice phone is (661) 945-5984.

Dr. Mahabadi's primary practice is High Desert Medical Group in Lancaster, California. Dr. Mahabadi is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is High Desert Medical Group. Dmand AI also links Dr. Mahabadi to 2 more group practices and clinics, 1 physician office, 1 home health agency and 1 medical group, each named with a free account. Dr. Mahabadi's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mahabadi practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mahabadi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mahabadi is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mahabadi is licensed in California.

Dmand AI lists asthma, chronic diabetes, chronic hypertension, chronic obstructive pulmonary disease (COPD), heart failure and lupus among the conditions Dr. Mahabadi treats.

CMS data shows 577 Medicare services from Dr. Mahabadi across 6 procedure codes in 2024, for 134 Medicare patients. Medicare paid $52,003 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 134 Medicare patients who saw Dr. Mahabadi in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mahabadi's median patient age at 72, with 59% women.

In 2024, Dr. Mahabadi wrote 233 Medicare Part D claims for 69 patients. 85% of them were for generic drugs. CMS names the drug for 30 of them, across 2 drugs with 11 or more claims each, at $279 in total drug cost. In 2023, CMS named 56 claims across 4 drugs.

CMS lists Dr. Mahabadi as offering telehealth.

Dmand AI links 5 papers to Dr. Mahabadi, published from 2021 to 2024. 2022 was the busiest year, with 2. The most frequent topics are Black or African American and Socioeconomic Factors. Dr. Mahabadi has published most often in Cureus. Dr. Mahabadi's most frequent co-authors are Rashid Alhusain, Mohammed T. Ali, BAO, BCH, MB and M Safwan Badr, MD.

CMS Open Payments shows 22 general payments to Dr. Mahabadi from 12 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $189.

Dr. Mahabadi graduated from Arizona School of Dentistry and Oral Health - Mesa in 2019.

Dr. Mahabadi is in network with 2 carriers, including Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.